Relay Therapeutics annual revenue
2020
2021
2022
2023
2024
2025
Relay Therapeutics Revenue Growth & History (RLAY)
Relay Therapeutics reported $15.4M in revenue for fiscal 2025, an increase of 53.44% from the previous fiscal year.
View full Relay Therapeutics company overviewRelay Therapeutics annual revenue and growth
| Fiscal year | Period ended | Revenue | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $15.4M | $5.3M | +53.44% |
| 2024 | 2024-12-31 | $10.0M | −$15.5M | −60.83% |
| 2023 | 2023-12-31 | $25.5M | $24.2M | +1749.82% |
| 2022 | 2022-12-31 | $1.4M | −$1.6M | −54.41% |
| 2021 | 2021-12-31 | $3.0M | −$79.6M | −96.34% |
| 2020 | 2020-12-31 | $82.7M | — | — |
Relay Therapeutics quarterly revenue
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Revenue | Change | YoY growth |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $350,000 | −$327,000 | −48.30% |
| Q1 2026 | 2026-03-31 | $3.0M | −$4.7M | −60.93% |
| Q4 2025 | 2025-12-31 | $7.0M | $7.0M | — |
| Q3 2025 | 2025-09-30 | $0 | $0 | — |
| Q2 2025 | 2025-06-30 | $677,000 | $677,000 | — |
| Q1 2025 | 2025-03-31 | $7.7M | −$2.3M | −23.26% |
| Q4 2024 | 2024-12-31 | $0 | $1,000 | +100.00% |
| Q3 2024 | 2024-09-30 | $0 | −$25.2M | −100.00% |
| Q2 2024 | 2024-06-30 | $0 | −$119,000 | −100.00% |
| Q1 2024 | 2024-03-31 | $10.0M | $9.8M | +4327.88% |
| Q4 2023 | 2023-12-31 | −$1,000 | −$254,000 | −100.40% |
| Q3 2023 | 2023-09-30 | $25.2M | $24.9M | +7226.16% |
| Q2 2023 | 2023-06-30 | $119,000 | −$246,000 | −67.40% |
| Q1 2023 | 2023-03-31 | $226,000 | −$193,000 | −46.06% |
| Q4 2022 | 2022-12-31 | $253,000 | −$314,000 | −55.38% |
| Q3 2022 | 2022-09-30 | $344,000 | −$322,000 | −48.35% |
| Q2 2022 | 2022-06-30 | $365,000 | −$479,000 | −56.75% |
| Q1 2022 | 2022-03-31 | $419,000 | −$533,000 | −55.99% |
| Q4 2021 | 2021-12-31 | $567,000 | — | — |
| Q3 2021 | 2021-09-30 | $666,000 | — | — |
| Q2 2021 | 2021-06-30 | $844,000 | — | — |
| Q1 2021 | 2021-03-31 | $952,000 | — | — |
Relay Therapeutics revenue growth trends
Over the last five reported fiscal years, revenue declined from $82.7M to $15.4M, a compound annual decline of 28.58%. Relay Therapeutics's latest reported quarter, Q2 2026, generated $350,000 in revenue, a decrease of 48.30% year over year.
About the data
What revenue means
Revenue is the top-line amount a company reports from selling goods and services before expenses are deducted. Fiscal periods can differ from calendar years, so each table includes the exact period end date.
Financial data
Standardized company financials
TickerStat standardizes company financial facts for consistent comparison. Derived growth rates use the displayed values and are not guidance or forecasts.
Review Relay Therapeutics source filings ↗